Results 181 to 190 of about 711,937 (246)

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy. [PDF]

open access: yesBlood Adv
Le Henaff JR   +34 more
europepmc   +1 more source

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

open access: yesJAMA Neurol
Möhn N   +52 more
europepmc   +1 more source

Progressive Multifocal Leukoencephalopathy

Seminars in Neurology, 1999
Before the AIDS epidemic, progressive multifocal leukoencephalopathy (PML) was a rare disorder occurring most often in association with leukemia and lymphoma. Current estimates indicate that PML ultimately develops in up to 5% of all patients with AIDS.
Eugene O Major
exaly   +3 more sources

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence

Multiple Sclerosis Journal, 2019
Background: Progressive multifocal leukoencephalopathy (PML) is the main safety concern for dimethyl fumarate (DMF) treatment in persons with multiple sclerosis (pwMS).
Martin Diebold   +2 more
exaly   +2 more sources

Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.

Neurology, 2023
JC polyomavirus (JCV) establishes an asymptomatic latent and/or persistent infection in most of the adult population. However, in immunocompromised individuals, JCV can cause a symptomatic infection of the brain, foremost progressive multifocal ...
F. Schweitzer   +8 more
semanticscholar   +1 more source

Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.

The Lancet Haematology, 2021
Progressive multifocal leukoencephalopathy (PML) is a serious and usually fatal CNS infection caused by the John Cunningham virus. CD4+ and CD8+ T-cell lymphopenia, resulting from HIV infection, chemotherapy, or immunosuppressive therapy, are primary ...
C. Bennett   +9 more
semanticscholar   +1 more source

Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin‐7

Annals of Neurology, 2022
Restoring anti‐JC virus (JCV) immunity is the only treatment of progressive multifocal leukoencephalopathy (PML). Interleukin‐7 is a cytokine that increases number and function of T cells. We analyzed a population of PML patients who received recombinant
Rébecca Lajaunie   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy